Nanoparticle-mediated local delivery of Methylprednisolone after spinal cord injury.

[1]  Volker K. H. Sonntag,et al.  A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury , 2010 .

[2]  Effects of Amphotericin B on the expression of neurotoxic and neurotrophic factors in cultured microglia , 2008, Neurochemistry International.

[3]  Stacie A. Chvatal,et al.  Spatial distribution and acute anti-inflammatory effects of Methylprednisolone after sustained local delivery to the contused spinal cord. , 2008, Biomaterials.

[4]  M. Gladwin,et al.  Chemiluminescent detection of S-nitrosated proteins: comparison of tri-iodide, copper/CO/cysteine, and modified copper/cysteine methods. , 2008, Methods in enzymology.

[5]  C. Bonilla,et al.  Early administration of methylprednisolone decreases apoptotic cell death after spinal cord injury. , 2006, Histology and histopathology.

[6]  Michael G Fehlings,et al.  Pharmacological approaches to repair the injured spinal cord. , 2006, Journal of neurotrauma.

[7]  Young-tae Kim,et al.  In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury. , 2006, Biomaterials.

[8]  M. Sipski,et al.  High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients , 2005, Spinal Cord.

[9]  E. Antal,et al.  Influence of route of administration on the pharmacokinetics of methylprednisolone , 1983, Journal of Pharmacokinetics and Biopharmaceutics.

[10]  G. Gillies,et al.  A realistic brain tissue phantom for intraparenchymal infusion studies. , 2004, Journal of neurosurgery.

[11]  E. Hall.  Neuroprotective actions of glucocorticoid and nonglucocorticoid steroids in acute neuronal injury , 1993, Cellular and Molecular Neurobiology.

[12]  J. Mcdonald,et al.  RESTORING FUNCTION AFTER SPINAL CORD INJURY , 2003, The neurologist.

[13]  N. Ilhan,et al.  Effects of methylprednisolone and dextromethorphan on lipid peroxidation in an experimental model of spinal cord injury , 2002, Neurosurgical Review.

[14]  M. Fehlings,et al.  Epidemiology, demographics, and pathophysiology of acute spinal cord injury. , 2001, Spine.

[15]  J. Legos,et al.  Coadministration of Methylprednisolone with Hypertonic Saline Solution Improves Overall Neurological Function and Survival Rates in a Chronic Model of Spinal Cord Injury , 2001, Neurosurgery.

[16]  C. Hulsebosch,et al.  Bcl-xL expression after contusion to the rat spinal cord. , 2001, Journal of neurotrauma.

[17]  Y Li,et al.  PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Gyeong-Moon Kim,et al.  Glucocorticoid Receptor-Mediated Suppression of Activator Protein-1 Activation and Matrix Metalloproteinase Expression after Spinal Cord Injury , 2001, The Journal of Neuroscience.

[19]  C. Bernards,et al.  Spinal Cord Bioavailability of Methylprednisolone after Intravenous and Intrathecal Administration: The Role of P-Glycoprotein , 2000, Anesthesiology.

[20]  M. Oudega,et al.  Long‐term effects of methylprednisolone following transection of adult rat spinal cord , 1999, The European journal of neuroscience.

[21]  H. Winn,et al.  Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. , 1998, Journal of neurosurgery.

[22]  J. Xu,et al.  Methylprednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats. , 1998, Brain research. Molecular brain research.

[23]  E. Hogan,et al.  A new mechanism of methylprednisolone and other corticosteroids action demonstrated in vitro: inhibition of a proteinase (calpain) prevents myelin and cytoskeletal protein degradation , 1997, Brain Research.

[24]  J. L. Rodriguez,et al.  Consequences of high-dose steroid therapy for acute spinal cord injury. , 1997, The Journal of trauma.

[25]  K. Fukuzawa,et al.  Roles of nitric oxide in compression injury of rat spinal cord. , 1996, Free radical biology & medicine.

[26]  H. Dai,et al.  Methods to Assess the Development and Recovery of Locomotor Function after Spinal Cord Injury in Rats , 1993, Experimental Neurology.

[27]  E. Hall,et al.  The neuroprotective pharmacology of methylprednisolone. , 1992, Journal of neurosurgery.

[28]  W. Collins,et al.  A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. , 1991, The New England journal of medicine.

[29]  D Giulian,et al.  Characterization of ameboid microglia isolated from developing mammalian brain , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.